Protalix BioTherapeutics, Inc. Share Price
PLXProtalix BioTherapeutics, Inc. Stock Performance
Open $2.21 | Prev. Close $2.25 | Circuit Range N/A |
Day Range $2.19 - $2.29 | Year Range $1.32 - $3.19 | Volume 60,589 |
Average Traded $2.24 |
Protalix BioTherapeutics, Inc. Share Price Chart
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Protalix BioTherapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $2.26 | $2.25 | +2.27% |
07-Apr-26 | $2.18 | $2.20 | -0.45% |
06-Apr-26 | $2.17 | $2.21 | +3.03% |
02-Apr-26 | $2.15 | $2.15 | -1.15% |
01-Apr-26 | $2.21 | $2.17 | -0.91% |
31-Mar-26 | $2.11 | $2.19 | +4.78% |
30-Mar-26 | $2.11 | $2.09 | -2.56% |
FAQs on Protalix BioTherapeutics, Inc. Share Price
Can I buy Protalix BioTherapeutics, Inc. shares in India?
What is the share price of Protalix BioTherapeutics, Inc.?
What is the 5 year returns of Protalix BioTherapeutics, Inc.?
What are the high & low stock price of Protalix BioTherapeutics, Inc. today?
What is the 52-week high and low of Protalix BioTherapeutics, Inc. stock?